-
公开(公告)号:BRPI0508219A
公开(公告)日:2007-07-17
申请号:BRPI0508219
申请日:2005-02-18
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: MARTIS LEO , PATEL MEHUL , GIERTYCH JOSEPH A , MONGOVEN JAMES W , KUNZLER JACQUELINE A , OWEN WILLIAM F JR
Abstract: Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions are provided. A novel cause of aseptic peritonitis is provided—aseptic peritonitis associated with gram positive microbial contamination of a dialysis solution. Peptidoglycan is a major component of a gram positive bacterial cell wall and thus can serve as a marker for gram positive bacteria. In this regard, testing for peptidoglycans can be utilized to effectively prevent peritonitis in patients that use the peritoneal dialysis solutions, such as peritoneal dialysis solutions that contain a glucose polymer including an icodextrin and the like.
-
公开(公告)号:DK1131077T3
公开(公告)日:2006-11-27
申请号:DK00950792
申请日:2000-07-27
Applicant: BAXTER INT
Inventor: FAICT DIRK , BALTEAU PATRICK , MARTIS LEO , DUPONCHELLE ANNICK , HARTMAN JEAN-PIERRE , PELUSO FRANCESCO
-
公开(公告)号:HK1088535A1
公开(公告)日:2006-11-10
申请号:HK06108881
申请日:2006-08-10
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: MARTIS LEO , CHOO CAROLYN , ZIESKE PAUL
IPC: A61K20060101 , A61K31/718 , A61K31/724 , A61M20060101 , A61M1/28
Abstract: Icodextrin-based solutions and methods of making same that can be used during medical therapy, such as dialysis therapy are provided. The icodextrin-based solution at least includes a first solution containing icodextrin at a pH ranging from about 1.5 to about 5.0 and a buffer solution at a pH ranging from about 7.0 to about 12.0 that are so constructed and arranged allowing the icodextrin-based solution to be mixed prior to infusion into a patient. The icodextrin-based solutions of the present invention can be made at physiologic pH and with minimal glucose degradation products.
-
公开(公告)号:AT339213T
公开(公告)日:2006-10-15
申请号:AT00950792
申请日:2000-07-27
Applicant: BAXTER INT
Inventor: DUPONCHELLE ANNICK , FAICT DIRK , BALTEAU PATRICK , HARTMAN JEAN-PIERRE , MARTIS LEO , PELUSO FRANCESCO
-
公开(公告)号:CA2129998C
公开(公告)日:2006-07-11
申请号:CA2129998
申请日:1993-12-10
Applicant: BAXTER INT
Inventor: MARTIS LEO , JONES MICHAEL R
IPC: A61M1/14 , A61K9/08 , A61K31/195 , A61K31/198 , A61K31/40 , A61K31/405 , A61K31/415 , A61K33/10 , A61K33/14 , A61M1/28 , A61P13/00 , A61P13/02 , A61P15/00
Abstract: The present invention provides a dialysis solution that contains amino acids for treating and/or preventing malnutrition in a peritoneal dialysis patient. The amino acid composition is optimized to mininxize metabolic acidosis while normalizing amino acid plasma profile levels.
-
公开(公告)号:AU2003299683A1
公开(公告)日:2004-07-22
申请号:AU2003299683
申请日:2003-12-18
Applicant: BAXTER INT
Inventor: MARTIS LEO , CHOO CAROLYN , ZIESKE PAUL
IPC: A61K31/718 , A61K31/724 , A61M1/28
Abstract: Icodextrin-based solutions and methods of making same that can be used during medical therapy, such as dialysis therapy are provided. The icodextrin-based solution at least includes a first solution containing icodextrin at a pH ranging from about 1.5 to about 5.0 and a buffer solution at a pH ranging from about 7.0 to about 12.0 that are so constructed and arranged allowing the icodextrin-based solution to be mixed prior to infusion into a patient. The icodextrin-based solutions of the present invention can be made at physiologic pH and with minimal glucose degradation products.
-
公开(公告)号:ES2185646T3
公开(公告)日:2003-05-01
申请号:ES94903603
申请日:1993-12-10
Applicant: BAXTER INT
Inventor: MARTIS LEO , JONES MICHAEL R
IPC: A61K31/195 , A61K31/198 , A61K31/40 , A61K31/405 , A61K31/415 , A61K33/10 , A61K33/14 , A61M1/28 , A61P13/00 , A61P13/02 , A61P15/00 , A61K9/08 , A61P3/00
Abstract: The present invention provides a dialysis solution that contains amino acids for treating and/or preventing malnutrition in a peritoneal dialysis patient. The amino acid composition is optimized to minimize metabolic acidosis while normalizing amino acid plasma profiles.
-
公开(公告)号:DE69527923D1
公开(公告)日:2002-10-02
申请号:DE69527923
申请日:1995-05-25
Applicant: BAXTER INT
Inventor: MARTIS LEO , HENDERSON W
IPC: A61K9/08 , A61K31/19 , A61K31/194 , A61K31/70 , A61K31/7004 , A61K33/00 , A61K33/10 , A61K33/14 , A61M1/28 , A61P7/08 , A61P13/12 , A61M1/16
Abstract: A peritoneal dialysis solution that is biochemically balanced to correct metabolic acidosis associated with chronic renal failure in a more physiological manner. The peritoneal dialysis solution has a physiological pH, e.g. pH of 70 to 74 and contains bicarbonate at a concentration that is found in normal blood. Additionally, the solution contains carbon dioxide at a partial pressure that is similar to partial pressure of carbon dioxide found in normal blood. The peritoneal dialysis solution also contains a weak acid with a pKa of less than 5.0.
-
公开(公告)号:DE69332106D1
公开(公告)日:2002-08-14
申请号:DE69332106
申请日:1993-12-10
Applicant: BAXTER INT
Inventor: MARTIS LEO , FAICT DIRK , BURKE RON
IPC: A61K9/08 , A61K31/70 , A61K33/00 , A61K38/00 , A61K38/01 , A61K38/02 , A61K47/26 , A61K47/42 , A61M1/14 , A61M1/28 , A61P7/08 , A61M1/18
Abstract: The solution contains as osmotic agents both dectrose and polypeptides. The polypeptides are synthetic and are 4 to 10 amino acids long.
-
公开(公告)号:DE69330189D1
公开(公告)日:2001-06-07
申请号:DE69330189
申请日:1993-12-10
Applicant: BAXTER INT
Inventor: MARTIS LEO , FAICT DIRK , BURKE RON
IPC: A61K9/08 , A61K31/70 , A61K33/00 , A61K38/00 , A61K38/01 , A61K38/02 , A61K47/26 , A61K47/42 , A61M1/14 , A61M1/28 , A61P7/08 , A61M1/18
Abstract: The solution contains as osmotic agents both dectrose and polypeptides. The polypeptides are synthetic and are 4 to 10 amino acids long.
-
-
-
-
-
-
-
-
-